Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target
Open Access
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 158, 60-72
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
- University of Queensland
This publication has 51 references indexed in Scilit:
- Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networksJournal of Biomolecular NMR, 2013
- ICA-105574 Interacts with a Common Binding Site to Elicit Opposite Effects on Inactivation Gating of EAG and ERG Potassium ChannelsMolecular Pharmacology, 2013
- Spider-Venom Peptides: Structure, Pharmacology, and Potential for Control of Insect PestsAnnual Review of Entomology, 2013
- Tuning of EAG K+ channel inactivation: Molecular determinants of amplification by mutations and a small moleculeJournal of General Physiology, 2012
- Molecular Cloning and Sequence Analysis of the cDNAs Encoding Toxin-Like Peptides from the Venom Glands of TarantulaGrammostola roseaInternational Journal of Peptides, 2012
- Spider-Venom Peptides as TherapeuticsToxins, 2010
- ArachnoServer 2.0, an updated online resource for spider toxin sequences and structuresNucleic Acids Research, 2010
- MolProbity: all-atom contacts and structure validation for proteins and nucleic acidsNucleic Acids Research, 2007
- Mechanism of Block of hEag1 K+ Channels by Imipramine and AstemizoleJournal of General Physiology, 2004
- Potassium Currents Expressed from Drosophila and Mouse eag cDNAs in Xenopus OocytesNeuropharmacology, 1996